Friday, 25 September 2026European Markets

ALMUNDA PRO NV And NEURONES Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(vianews) - almunda pro nv (amund.as) is among this list of stock assets with the highest dividend rate and return on equity on the technology sector.

financial asset price forward dividend yield return on equity
almunda pro nv (amund.as) €1.13 5.22% 6.32%
neurones (nro.pa) €45.80 2.61% 14.87%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. almunda pro nv (amund.as)

5.22% forward dividend yield and 6.32% return on equity

almunda professionals n.v. provides digital transformation, data management, regulatory change, and consultancy services in the netherlands and internationally. the company was formerly known as novisource n.v. and changed its name to almunda professionals n.v. in august 2021. almunda professionals n.v. was founded in 2001 and is headquartered in amsterdam, the netherlands.

earnings per share

as for profitability, almunda pro nv has a trailing twelve months eps of €0.02.

pe ratio

almunda pro nv has a trailing twelve months price to earnings ratio of 56.5. meaning, the purchaser of the share is investing €56.5 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.32%.

volume

today's last reported volume for almunda pro nv is 78 which is 95.06% below its average volume of 1581.

revenue growth

year-on-year quarterly revenue growth grew by 20.3%, now sitting on 30.01m for the twelve trailing months.

yearly top and bottom value

almunda pro nv's stock is valued at €1.13 at 02:30 est, way under its 52-week high of €1.34 and higher than its 52-week low of €1.08.

more news about almunda pro nv.

2. neurones (nro.pa)

2.61% forward dividend yield and 14.87% return on equity

neurones s.a., an information technology (it) services company, provides infrastructure, application, and consulting services in france and internationally. its infrastructure services include infrastructure management, manages public and private cloud services, it operations, user support, devops, cybersecurity, it service management, information system governance, and automation. the company also provides application services in the areas of sap, digital, web, mobility, ux/ui, enterprise content and document management, business process management, robotic process automation, dematerialization, it consulting for finance, big data, and devops, it training and change management, and innovation connected devices (iot). in addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, devops, ci/cd, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, ux/ui, and digital marketing, as well as internal process digitization, ecm/bpm, rpa, dematerialization, ai, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. the company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. neurones s.a. was founded in 1984 and is based in nanterre, france.

earnings per share

as for profitability, neurones has a trailing twelve months eps of €1.96.

pe ratio

neurones has a trailing twelve months price to earnings ratio of 23.37. meaning, the purchaser of the share is investing €23.37 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.87%.

volume

today's last reported volume for neurones is 2114 which is 75.38% below its average volume of 8587.

more news about neurones.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com